secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2023-05-12T23:59:59+00:00
Accession:  0001493152-23-016746
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions posts Q3 net loss $6.34M on $457K rev; goodwill impairment $4.1M
--------------------------------------------------------------------------------

- Combined revenue & govt support $574,738 (+199% YoY); product revenue $457,058 from Intelligent Fingerprinting acquisition.
- Net loss $6.34M ($5.72 per share) vs $1.34M ($1.79) prior year; includes $4.1M non-cash goodwill impairment.
- Filed 513(g) FDA submission for drug screening cartridge; granted UK patent for DSR-Plus Cartridge Reader (13th patent).
- Completed biosensor Milestone 7: 4x improvement in time-to-result (<1 min); advancing to human saliva testing.
- Cash and equivalents $2.3M as of March 31, 2023; new sales team and distribution hub established in Australia.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315223016746/0001493152-23-016746-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315223016746/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-016746

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer